Valuation: genOway

Market Cap 22.59M 26.17M 21.19M 19.3M 36.29M 2.5B 36.8M 248M 97.35M 1.25B 98.24M 96.11M 4.17B P/E 2024 *
-
P/E 2025 -
Enterprise Value 29.31M 33.95M 27.5M 25.04M 47.09M 3.25B 47.74M 322M 126M 1.63B 127M 125M 5.41B EV / Sales 2024
1.28x
EV / Sales 2025 1.11x
Free-Float
59.02%
Yield 2024 *
-
Yield 2025 -
1 day+0.82%
1 week-1.20%
Current month+1.23%
1 month-0.40%
3 months+2.07%
6 months+2.07%
Current year-8.86%
1 week 2.43
Extreme 2.43
2.58
1 month 2.4
Extreme 2.4
2.58
Current year 2.18
Extreme 2.18
2.79
1 year 2.1
Extreme 2.1
3.2
3 years 2.1
Extreme 2.1
4.91
5 years 2.1
Extreme 2.1
4.91
10 years 1
Extreme 1
7.7
Manager TitleAgeSince
Chief Executive Officer - -
Chief Operating Officer - 28/02/1999
Director of Finance/CFO - 30/09/2015
Director TitleAgeSince
Director/Board Member - 28/02/1999
Chairman - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
20/01/22 Buy

Chief Executive Officer

12,500 0.1376%
17/11/21 Sell

Chief Executive Officer

5,000 0.0553%
13/11/21 Sell

Founder

1,147 0.0127%
Change 5-day change 1-year change 3-year change Capi.($)
+0.82%-1.20%-19.81%-31.58% 26.17M
-0.14%-1.74%+1.73%+19.81% 48.84B
+4.07%+2.43%+483.70%+623.80% 45.44B
+4.33%+0.98%+12.80%+88.53% 41.22B
+1.94%-0.31%+26.24%+12.62% 39.71B
-0.50%0.00%+20.60%+60.49% 32.6B
+0.10%-3.22% - - 16.25B
+3.22%-0.88%+30.42%+135.47% 16.67B
-0.63%-0.49%+3.30%+28.96% 14.08B
+2.35%+3.48%+82.95%+43.41% 13.68B
Average +1.56%-0.19%+71.33%+109.06% 26.85B
Weighted average by Cap. +1.85%+0.03%+103.04%+153.38%

Financials

2024 2025
Net sales 27.53M 31.89M 25.83M 23.53M 44.23M 3.05B 44.85M 303M 119M 1.53B 120M 117M 5.08B 28.6M 33.13M 26.83M 24.44M 45.95M 3.17B 46.59M 315M 123M 1.59B 124M 122M 5.28B
Net income 1.83M 2.12M 1.72M 1.56M 2.94M 203M 2.98M 20.13M 7.89M 102M 7.96M 7.79M 338M 928K 1.07M 870K 793K 1.49M 103M 1.51M 10.2M 4M 51.48M 4.03M 3.95M 171M
Net Debt 623K 722K 584K 532K 1M 69M 1.01M 6.85M 2.68M 34.57M 2.71M 2.65M 115M 6.72M 7.78M 6.3M 5.74M 10.79M 744M 10.94M 73.88M 28.95M 373M 29.22M 28.58M 1.24B
Logo genOway
genOway est une société de biotechnologie spécialisée dans la conception et le développement de modèles de recherche moléculaires, cellulaires et animaux à forte valeur ajoutée pour les industries biopharmaceutique, chimique, agrochimique et agroalimentaire ainsi que pour la recherche académique. genOway est une société leader sur son marché. Elle appuie son développement sur la combinaison d'une large et exclusive plateforme technologique et d'une propriété intellectuelle forte combinant brevets et licences d'exploitation. genOway a conclu de nombreux contrats commerciaux avec les leaders de l'industrie pharmaceutique (BMS, Janssen, Novartis, Pfizer, etc.), et avec les centres de recherche académiques les plus prestigieux (King's College et Université de Manchester en Angleterre, Harvard, Caltech et le National Institute of Health aux Etats-Unis, l'Institut Pasteur en France, le NGFN et l'Institut Max Planck en Allemagne, etc.).
Employees
157
Date Price Change Volume
18/08/26 2.470 +0.82% 600
17/08/26 €2.450 -1.21% 500
14/08/26 €2.480 0.00% 2,115
13/08/26 €2.480 -1.59% 5,147
12/08/26 €2.520 +0.80% 20,564
  1. Stock Market
  2. Stocks
  3. ALGEN Stock